Pharmaceuticals: Streamline the product life cycle
Create efficiencies that reduce costs and unlock innovation
Pharmaceutical companies face increased pressure surrounding drug pricing and reimbursement constraints. To stay competitive, they must continue to drive innovation in complex circumstances both internally and with their customers and patients.
An integrated and connected technology platform can help address these challenges. When systems, data, and processes are connected, pharma companies are better equipped to manage the essential steps of bringing a drug to market: clinical trials, supply chain, marketing, sales, and patient services. And in the pharmaceutical business, that not only means an increase in efficiency and cost savings for the company, but also an improvement in patient outcomes due to increased adherence and personalized support.
Decentralized clinical trials are associated with reduced trial timelines and can achieve net financial benefits of up to 14X
Navigating complex and disparate data silos across the value chain takes up a lot of valuable time when bringing a drug to market
Unifying data silos enables collaboration across teams and faster innovation by connecting trial teams, patients, and clinical data on a single digital platform. This makes it easier to see the entire research and development process and identify areas in need of greater efficiency.
Pharma companies have a hard time directly engaging with patients, making it hard to understand how well therapies work in the real world.
An integrated health platform brings everyone together creating more seamless connections between pharma companies, patients and their healthcare providers. These connections enable pharma companies to track therapy-specific programs and give them the opportunity to make program improvements when necessary.
Pharma companies have more patient data than ever before, but without a way to extract actionable insights, its value isn’t fully realized, and it can't be used to create a better experience for the patient
Integrated healthcare platforms unify data from disparate sources — including clinical and real-world — to create a richer data set from which to learn about customers, analyze therapy adherence and measure success. The additional layer of automation and AI then uses this data to give teams real-time insights they can act on.
The costs of clinical trials are rising. Challenges with patient recruitment and retention result in lost market opportunity, longer time to market, and challenges in achieving health equity.
Unifying teams and data on a single platform allows pharma companies to achieve greater transparency and collaboration. It makes it easier to recruit patients (including virtually), prevent attrition, share critical data securely between teams, and ensure compliance at every stage.
Cell and gene therapy is the next frontier for pharmaceutical treatment due to its ability to greatly improve outcomes for rare diseases. However, the advanced collaboration required to develop and deliver these types of treatments can be difficult for companies to both facilitate and support.
An integrated healthcare platform can streamline advanced therapy delivery, unlocking improved outcomes for patients. Technologies like AI can reduce expensive errors by providing visibility and proactively identifying bottlenecks across the multi-step process of delivering care.